Clinical Trial: Fluorescent Leukocytes as a Marker of Early Sepsis/Severity

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07585942) titled 'Fluorescent Leukocytes as a Marker of Early Sepsis/Severity' on May 06.

Brief Summary: Sepsis is a medical emergency whose prognosis depends on the early identification of patients at risk of septic shock, but the tools available in the Emergency Department remain insufficient. Neutrophils, key players in immunothrombosis, show alterations detectable via cell fluorescence (e.g., NE-SFL), which are strongly correlated with the severity of sepsis and septic DIC. The FLAMES study will evaluate, from the time of admission to the Emergency Department, the relevance of neutrophil fluorescence as an early biomarker of severity, either alone...